154 related articles for article (PubMed ID: 33494684)
1. Pemetrexed - First-Line Therapy for Non-Squamous Non-Small Cell Lung Cancer: A Review of Patent Literature.
Vora PA; Patel R; Dharamsi A
Recent Pat Anticancer Drug Discov; 2021; 16(3):333-349. PubMed ID: 33494684
[TBL] [Abstract][Full Text] [Related]
2. Bortezomib - First Therapeutic Proteasome Inhibitor for Cancer Therapy: A Review of Patent Literature.
Vora PA; Patel R; Dharamsi A
Recent Pat Anticancer Drug Discov; 2020; 15(2):113-131. PubMed ID: 32234004
[TBL] [Abstract][Full Text] [Related]
3. Nintedanib as the First Treatment for Group of Progressive Interstitial Lung Diseases: A Review of Patent Literature.
Trivedi MD; Dubal G; Vora PA
Recent Adv Inflamm Allergy Drug Discov; 2023; 17(2):96-109. PubMed ID: 37710999
[TBL] [Abstract][Full Text] [Related]
4. Levothyroxine Sodium - Thyroid Hormone Replacement Therapy for Hypothyroidism: A Review of Patent Literature.
Upadhyay U; Vora PA; Patel R; Prajapati B
Recent Pat Biotechnol; 2023; 17(3):245-256. PubMed ID: 36515027
[TBL] [Abstract][Full Text] [Related]
5. Pemetrexed: a multitargeted antifolate.
Rollins KD; Lindley C
Clin Ther; 2005 Sep; 27(9):1343-82. PubMed ID: 16291410
[TBL] [Abstract][Full Text] [Related]
6. Safety of Same-Day Vitamin B12 Supplementation in Patients Receiving Pemetrexed for the Treatment of Non-Small-Cell Lung Cancer or Pleural Mesothelioma: A Retrospective Analysis.
Schlei Z; Tan W; Faber MG; Chen H; Meagher A; Dy GK
Clin Lung Cancer; 2018 Nov; 19(6):467-475. PubMed ID: 30369425
[TBL] [Abstract][Full Text] [Related]
7. The evolving role of pemetrexed disodium for the treatment of non-small cell lung cancer.
Rossi G; Alama A; Genova C; Rijavec E; Tagliamento M; Biello F; Coco S; Dal Bello MG; Boccardo S; Grossi F
Expert Opin Pharmacother; 2018 Dec; 19(17):1969-1976. PubMed ID: 30354693
[TBL] [Abstract][Full Text] [Related]
8. Pemetrexed: a new cytotoxic agent in the development for first-line non-small-cell lung cancer.
Scagliotti GV
Lung Cancer; 2005 Oct; 50 Suppl 1():S18-9. PubMed ID: 16291426
[TBL] [Abstract][Full Text] [Related]
9. Pemetrexed disodium.
Gibbs D; Jackman A
Nat Rev Drug Discov; 2005 May; Suppl():S16-7. PubMed ID: 15962527
[TBL] [Abstract][Full Text] [Related]
10. The role of pemetrexed in second-line chemotherapy for advanced non-small cell lung cancer.
Tucker S
Curr Drug Targets; 2010 Jan; 11(1):58-60. PubMed ID: 19839927
[TBL] [Abstract][Full Text] [Related]
11. Salvage treatment with irinotecan/cisplatin versus pemetrexed/cisplatin in patients with non-small cell lung cancer pre-treated with a non-platinum-based regimen in the first-line setting: a randomized phase II study of the Hellenic Oncology Research Group (HORG).
Kentepozidis N; Economopoulou P; Christofyllakis C; Chelis L; Polyzos A; Vardakis N; Koinis F; Vamvakas L; Katsaounis P; Kalbakis K; Nikolaou C; Georgoulias V; Kotsakis A
Clin Transl Oncol; 2017 Mar; 19(3):317-325. PubMed ID: 27492015
[TBL] [Abstract][Full Text] [Related]
12. Patient-reported outcomes following pembrolizumab or placebo plus pemetrexed and platinum in patients with previously untreated, metastatic, non-squamous non-small-cell lung cancer (KEYNOTE-189): a multicentre, double-blind, randomised, placebo-controlled, phase 3 trial.
Garassino MC; Gadgeel S; Esteban E; Felip E; Speranza G; Domine M; Hochmair MJ; Powell S; Cheng SY; Bischoff HG; Peled N; Reck M; Hui R; Garon EB; Boyer M; Wei Z; Burke T; Pietanza MC; Rodríguez-Abreu D
Lancet Oncol; 2020 Mar; 21(3):387-397. PubMed ID: 32035514
[TBL] [Abstract][Full Text] [Related]
13. [Pemetrexed for Treatment of Nonsquamous Non-Small-Cell Lung Cancer].
Omori Y; Enatsu S
Gan To Kagaku Ryoho; 2018 Nov; 45(11):1609-1613. PubMed ID: 30449848
[TBL] [Abstract][Full Text] [Related]
14. Approval summary: pemetrexed maintenance therapy of advanced/metastatic nonsquamous, non-small cell lung cancer (NSCLC).
Cohen MH; Cortazar P; Justice R; Pazdur R
Oncologist; 2010; 15(12):1352-8. PubMed ID: 21148615
[TBL] [Abstract][Full Text] [Related]
15. Gefitinib: An Updated Review of its Role in the Cancer Management, its Nanotechnological Interventions, Recent Patents and Clinical Trials.
Kumar P; Mangla B; Javed S; Ahsan W; Musyuni P; Ahsan A; Aggarwal G
Recent Pat Anticancer Drug Discov; 2023; 18(4):448-469. PubMed ID: 36305149
[TBL] [Abstract][Full Text] [Related]
16. Treatment with or without bevacizumab as a first-line and maintenance therapy for advanced non-squamous non-small cell lung cancer: A retrospective study.
Jun N; Hanping W; Xiaoyan S; Yan X; Mengzhao W; Xiaotong Z; Li Z
Thorac Cancer; 2020 Jul; 11(7):1869-1875. PubMed ID: 32406994
[TBL] [Abstract][Full Text] [Related]
17. Phase II study of pemetrexed disodium, a multitargeted antifolate, and cisplatin as first-line therapy in patients with advanced nonsmall cell lung carcinoma: a study of the National Cancer Institute of Canada Clinical Trials Group.
Shepherd FA; Dancey J; Arnold A; Neville A; Rusthoven J; Johnson RD; Fisher B; Eisenhauer E
Cancer; 2001 Aug; 92(3):595-600. PubMed ID: 11505404
[TBL] [Abstract][Full Text] [Related]
18. Pemetrexed and its emerging role in the treatment of thoracic malignancies.
Scagliotti GV; Novello S
Expert Opin Investig Drugs; 2003 May; 12(5):853-63. PubMed ID: 12720495
[TBL] [Abstract][Full Text] [Related]
19. A Phase 1/1b Study Evaluating Trametinib Plus Docetaxel or Pemetrexed in Patients With Advanced Non-Small Cell Lung Cancer.
Gandara DR; Leighl N; Delord JP; Barlesi F; Bennouna J; Zalcman G; Infante JR; Reckamp KL; Kelly K; Shepherd FA; Mazieres J; Janku F; Gardner OS; Mookerjee B; Wu Y; Cox DS; Schramek D; Peddareddigari V; Liu Y; D'Amelio AM; Blumenschein G
J Thorac Oncol; 2017 Mar; 12(3):556-566. PubMed ID: 27876675
[TBL] [Abstract][Full Text] [Related]
20. An Open-Label, Multicenter, Randomized, Phase II Study of Cisplatin and Pemetrexed With or Without Cixutumumab (IMC-A12) as a First-Line Therapy in Patients With Advanced Nonsquamous Non-Small Cell Lung Cancer.
Novello S; Scagliotti G; de Castro G; Kiyik M; Kowalyszyn R; Deppermann KM; Arriola E; Bosquee L; Novosiadly RD; Nguyen TS; Forest A; Tang S; Kambhampati SRP; Cosaert J; Reck M
J Thorac Oncol; 2017 Feb; 12(2):383-389. PubMed ID: 27464970
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
